Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease - Wikidata - awgldk - TriplyDB

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

http://www.wikidata.org/entity/Q28828635

about

Patient-specific modeling of individual sickle cell behavior under transient hypoxia.Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus.A deep convolutional neural network for classification of red blood cells in sickle cell anemia.Single-shot dual-wavelength interferometric microscopy.Tomographic phase microscopy: principles and applications in bioimaging [Invited].Measurements of morphological and biophysical alterations in individual neuron cells associated with early neurotoxic effects in Parkinson's disease.Simultaneous polymerization and adhesion under hypoxia in sickle cell disease Synergistic Integration of Laboratory and Numerical Approaches in Studies of the Biomechanics of Diseased Red Blood Cells Shape oscillations of single blood drops: applications to human blood and sickle cell disease

P2860

Q30843061-7564C131-A4AB-42A8-87B8-24B356BDDA23 Q30850527-C8997954-FCAE-4D25-99FF-E15F952A7951 Q47110309-5567D028-B3F4-4E1F-9AEB-CB91DB8E4961 Q47402344-D5F6627E-6E0E-47A9-A07B-1A192CD8219F Q47553969-24891BB6-6E5B-40A8-B013-0E1D5F94B128 Q48662488-3BB73F46-8705-4B21-B6BF-C40918566D90 Q57031253-870861E1-4D5D-4062-8D79-FF4AAC0AE32B Q58788728-D2D4BA05-9247-4B7B-8628-223974FB7132 Q59136096-870FEAC9-4F92-41FE-85DA-AB5E88DBA76E

P2860

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

http://www.wikidata.org/entity/Q28828635

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@ast

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@en

type

label

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@ast

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@en

prefLabel

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@ast

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@en

P1433

Q28828635-D4D89508-8D39-40ED-87CD-BA6288A72525

P1476

Q28828635-F05F06C5-9056-4AE7-970F-54695878D39E

P2093

Q28828635-110908F8-DA59-41C5-B52C-08DC196E16CD

Q28828635-13115306-5CD9-4811-BE01-FD436C3EA522

Q28828635-1898BD9A-A62E-4DE6-9AD1-ED57CD3E270D

Q28828635-50D107EF-F69F-497D-9937-FA51507C414B

Q28828635-545EB9A3-B0E9-4421-8217-F2F0FF768753

Q28828635-6F7DB560-AC6B-4A0D-923E-0CA02729F005

Q28828635-992BE9C7-FEC0-4C52-9925-5AABC35BE9D8

Q28828635-B1EEB893-1137-4F59-8DF0-3E47E057B393

Q28828635-FAF17F47-FA06-468E-8792-53183A298DDB

P2860

Q28828635-009EFE22-4182-4AF6-87D9-FD379C089E38

Q28828635-0F4A25AB-4E05-4645-AE25-BC0421F7B92D

Q28828635-1C6C30F9-1794-494F-AACC-7AE3CB09AD25

Q28828635-2279E0C6-BBE4-4230-88AC-21D6A10E4F42

Q28828635-2CC3C81D-4D50-4554-A9ED-6083C2D8CC47

Q28828635-307064F2-A84D-4822-A8D6-20935E1A7613

Q28828635-3A87ECF3-3A7C-43AD-9AC1-E977AF7A38DC

Q28828635-3B085628-9130-4521-AE6C-A0413F6DF0F2

Q28828635-3B1FFC4F-4E36-4BB2-BDE2-F7910772770A

Q28828635-3D5239D3-E5B6-46D1-A1A7-006856313A38

P304

Q28828635-A0CD74F5-01B2-4F36-B952-E638AEC24194

P31

Q28828635-5D5B0657-5829-4A5E-A3D3-29351DAC5598

P356

Q28828635-F79B0881-7D3B-45E6-B3F8-5244771A8021

P407

Q28828635-2A1E3861-BEC5-44CA-A10F-0E3FFBA4B4F3

P433

Q28828635-155704BE-1048-4A35-B87A-B62D57DE170B

P478

Q28828635-DF57E5CE-F355-4577-BB6B-3B5E0D6D1905

P50

Q28828635-2ECA8311-8592-4C36-A2E4-F0E713671856

Q28828635-6E5AEF33-59EF-4AE5-A606-E49F904594A2

Q28828635-95DE27C2-0129-416A-ADE8-2B2936D32D0F

P577

Q28828635-AA7329A9-9EB0-4D4F-8D72-242976C08FDD

P698

Q28828635-42ADADCC-CECA-4F38-9641-1110B532E637

P921

Q28828635-5ED5C3ED-D5FA-4264-AF25-70E8F41D505A

P932

Q28828635-8791EDB0-1F67-483B-98AA-E191F5ACEBB7

P356

PNAS.1610435113

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease

@en

P2093

Dimitrios P Papageorgiou

http://www.w3.org/2001/XMLSchema#string

Gregory J Kato

http://www.w3.org/2001/XMLSchema#string

John M Higgins

http://www.w3.org/2001/XMLSchema#string

Peter T C So

http://www.w3.org/2001/XMLSchema#string

Poorya Hosseini

http://www.w3.org/2001/XMLSchema#string

Sabia Z Abidi

http://www.w3.org/2001/XMLSchema#string

YongKeun Park

http://www.w3.org/2001/XMLSchema#string

Youngwoon Choi

http://www.w3.org/2001/XMLSchema#string

Zahid Yaqoob

http://www.w3.org/2001/XMLSchema#string

P2860

Red cell membrane: past, present, and future

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Structure and deformation properties of red blood cells: concepts and quantitative methods.

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Sickle cell vasoocclusion and rescue in a microfluidic device.

Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles

Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice

A biophysical indicator of vaso-occlusive risk in sickle cell disease.

Model function to calculate the refractive index of native hemoglobin in the wavelength range of 250-1100 nm dependent on concentration.

Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation

P304

9527-9532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1610435113

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27512047

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

5003247

http://www.w3.org/2001/XMLSchema#string